Get started
VANDA PHARMACE INC COM STK USD0.001VANDA PHARMACE INC COM STK USD0.001VANDA PHARMACE INC COM STK USD0.001

VANDA PHARMACE INC COM STK USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0LKB chart


Full chart

Key facts today

Vanda Pharmaceuticals Inc. announced that its product candidate VGT-1849A has received orphan drug designation from the US FDA for the treatment of polycythemia vera, a rare blood cancer.
Analyze the impactAnalyze the impact

0LKB upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪269.97 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.28 USD
Net income (FY)
‪2.51 M‬ USD
Revenue (FY)
‪192.64 M‬ USD
Shares float
‪55.22 M‬
Beta (1Y)
0.48

Employees


Employees (FY)
203
Change (1Y)
−87 −30.00%
Revenue / Employee (1Y)
‪948.97 K‬ USD
Net income / Employee (1Y)
‪12.36 K‬ USD

About Vanda Pharmaceuticals Inc.


Sector
Health Technology
CEO
Mihael Hristos Polymeropoulos
Headquarters
Washington
Website
vandapharma.com
Founded
2002
FIGI
BBG00JVXHHT4
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0LKB news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0LKB is 4.60 USD — it has increased by 1.01% in the past 24 hours. Watch VANDA PHARMACE INC COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VANDA PHARMACE INC COM STK USD0.001 stocks are traded under the ticker 0LKB.
0LKB stock has risen by 0.04% compared to the previous week, the month change is a −5.98% fall, over the last year VANDA PHARMACE INC COM STK USD0.001 has showed a 17.52% increase.
We've gathered analysts' opinions on VANDA PHARMACE INC COM STK USD0.001 future price: according to them, 0LKB price has a max estimate of 18.00 USD and a min estimate of 5.50 USD. Watch 0LKB chart and read a more detailed VANDA PHARMACE INC COM STK USD0.001 stock forecast: see what analysts think of VANDA PHARMACE INC COM STK USD0.001 and suggest that you do with its stocks.
0LKB reached its all-time high on Dec 4, 2018 with the price of 32.36 USD, and its all-time low was 3.30 USD and was reached on Nov 10, 2023. View more price dynamics on 0LKB chart.
See other stocks reaching their highest and lowest prices.
0LKB stock is 1.46% volatile and has beta coefficient of 0.48. Track VANDA PHARMACE INC COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is VANDA PHARMACE INC COM STK USD0.001 there?
Today VANDA PHARMACE INC COM STK USD0.001 has the market capitalization of ‪278.71 M‬, it has increased by 1.28% over the last week.
Yes, you can track VANDA PHARMACE INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
VANDA PHARMACE INC COM STK USD0.001 is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
0LKB earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.16 USD resulting in a 42.55% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about VANDA PHARMACE INC COM STK USD0.001 earnings.
VANDA PHARMACE INC COM STK USD0.001 revenue for the last quarter amounts to ‪47.65 M‬ USD, despite the estimated figure of ‪49.17 M‬ USD. In the next quarter, revenue is expected to reach ‪52.25 M‬ USD.
0LKB net income for the last quarter is ‪−5.32 M‬ USD, while the quarter before that showed ‪−4.52 M‬ USD of net income which accounts for −17.84% change. Track more VANDA PHARMACE INC COM STK USD0.001 financial stats to get the full picture.
No, 0LKB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 203.00 employees. See our rating of the largest employees — is VANDA PHARMACE INC COM STK USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VANDA PHARMACE INC COM STK USD0.001 EBITDA is ‪−30.16 M‬ USD, and current EBITDA margin is −5.68%. See more stats in VANDA PHARMACE INC COM STK USD0.001 financial statements.
Like other stocks, 0LKB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VANDA PHARMACE INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VANDA PHARMACE INC COM STK USD0.001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VANDA PHARMACE INC COM STK USD0.001 stock shows the sell signal. See more of VANDA PHARMACE INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.